Concord Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
7,759
+91
| +1% | +$16.9K | 0.21% | 105 |
|
|
2025
Q1 | $1.61M | Sell |
7,668
-21,812
| -74% | -$4.57M | 0.26% | 91 |
|
|
2024
Q4 | $5.24M | Buy |
29,480
+2,408
| +9% | +$428K | 0.86% | 26 |
|
|
2024
Q3 | $5.35M | Buy |
27,072
+1,369
| +5% | +$270K | 0.89% | 27 |
|
|
2024
Q2 | $4.41M | Buy |
25,703
+2,838
| +12% | +$487K | 0.78% | 31 |
|
|
2024
Q1 | $4.16M | Buy |
22,865
+3,228
| +16% | +$588K | 0.75% | 34 |
|
|
2023
Q4 | $3.04M | Buy |
19,637
+5,869
| +43% | +$910K | 0.61% | 40 |
|
|
2023
Q3 | $2.05M | Buy |
13,768
+3,198
| +30% | +$477K | 0.44% | 42 |
|
|
2023
Q2 | $1.42M | Buy |
10,570
+4,650
| +79% | +$626K | 0.31% | 53 |
|
|
2023
Q1 | $944K | Buy |
5,920
+4,066
| +219% | +$648K | 0.27% | 49 |
|
|
2022
Q4 | $300K | Sell |
1,854
-1,025
| -36% | -$166K | 0.09% | 122 |
|
|
2022
Q3 | $386K | Sell |
2,879
-378
| -12% | -$50.7K | 0.12% | 109 |
|
|
2022
Q2 | $499K | Buy |
3,257
+577
| +22% | +$88.4K | 0.14% | 98 |
|
|
2022
Q1 | $434K | Buy |
2,680
+308
| +13% | +$49.9K | 0.11% | 113 |
|
|
2021
Q4 | $321K | Buy |
2,372
+1,437
| +154% | +$194K | 0.08% | 138 |
|
|
2021
Q3 | $101K | Sell |
935
-638
| -41% | -$68.9K | 0.04% | 135 |
|
|
2021
Q2 | $177K | Sell |
1,573
-345
| -18% | -$38.8K | 0.05% | 150 |
|
|
2021
Q1 | $208K | Sell |
1,918
-142
| -7% | -$15.4K | 0.07% | 127 |
|
|
2020
Q4 | $221K | Buy |
+2,060
| New | +$221K | 0.17% | 66 |
|